Swiss registry following people with diabetes across Switzerland over time
Collects health data from adults with diabetes treated at Swiss study centers.
Plain-language title generated from the registry record
Registry title: Swiss Diabetes Registry - SwissDiab Study
Key facts
- Where
- Bern, Lausanne, Sankt Gallen, and Zurich, SwitzerlandSee the 4 sites
Where in Switzerland
- Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital BernBern, SwitzerlandTaking people
- Service d'endocrinologie, diabétologie et métabolismeLausanne, SwitzerlandTaking people
- Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.GallenSankt Gallen, SwitzerlandTaking people
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital ZürichZurich, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Insel Gruppe AG, University Hospital Bern
- Trial code
- NCT01179815
- Record updated
- 11 June 2026
- Original description
Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular and microvascular diseases. Therefore, treatment guidelines were established internationally by large and renowned associations and adopted by many countries.Read full original descriptionShow less
Swiss Diabetes Registry - SwissDiab Study, a Prospective Cohort Study of Patients With Diabetes in Switzerland
Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular and microvascular diseases. Therefore, treatment guidelines were established internationally by large and renowned associations and adopted by many countries.
For Switzerland only sparse data exist on the actual implementation of such recommendations and on patient's well-being. The Swiss Diabetes Registry - SwissDiab Study is a prospective cohort study aiming at including and collecting data of virtually all patients regularly seen and treated at the study centers (≈ 500 patients each), irrespective of type, duration of diabetes or treatment . This allows the evaluation of diabetes treatment strategies at these centers. Furthermore, risk indicators for micro- and macrovascular complications, mortality as well as costs and quality of life will be assessed. Data will be recorded through an internet-based, electronic database specifically designed for this study. At a later perspective it is planned to extend data collection to general practitioner/family doctor networks in order to include a larger and more representative sample of patients with diabetes in Switzerland.
Inclusion: Age > 18 years; Diagnosis of diabetes mellitus according to ADA criteria; Informed consent.
Exclusion: Patients with gestational diabetes mellitus, patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions as well as patients with significantly reduced life expectancy (<1 year) will be excluded.